Something I’ve come to notice is that both the approaches to treatment, and also the treatments available, can vary fairly significantly by country. There can also be considerations around access to care (eg health insurance in the US, NHS in the UK, Medicare in Australia) which may need to be factored in.
I wonder hence if it might be helpful to recommend including your location in forum signatures. Just country-level is probably sufficient given most folk would likely consider some domestic travel for treatments (although US patients may want to include their state as well).
Male 37; Melbourne, Australia
10/2018 Dx 3.5cm RC adenocarcinoma, 12cm from AV
Mod diff, EMVI+ LVI+ PNI-
3 LN; 4 liver mets, resectable
pT3pN1apM1a; Stage IVa. MSS, NRAS (G13R)
CEA: Oct-18= 12; Nov-18= 14, Mar-19= 2.4, Aug-19 <2.0
11/18 - FOLFOX x 6
3/19 - Liver resection
4-5/19 - 25 x pelvic radiation; complete met. response, TRG 3
07/19 - ULAR (robot), temp ileo, 1/27 LN+
08/19 - Missed liver spot
08/19 - FOLFOX x 1, FOLFOXIRI x 1, FOLFIRI x 2
10/19 - Planned liver resection #2 & ileo reversal